IP Library › Granted Patent US 12,607,877
Granted Patent B2
US 12,607,877 · App. 17/822,818 · Granted Apr 21, 2026

Contact lens product

Inventors: En-Ping Lin (Taichung City, TW); Wei-Yuan Chen (Taichung City, TW); Chun-Hung Teng (Taichung City, TW)
Assignee: LARGAN MEDICAL CO., LTD.
G02C7/049G02C7/04G02C7/041G02C7/042G02C7/044G02C2202/06G02C2202/22G02C2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,607,877
App. No.
17/822,818
Granted
Apr 21, 2026
Kind
B2
Abstract

A contact lens product includes a multifocal contact lens and a buffer solution. The multifocal contact lens includes a central region and at least one annular region. The annular region concentrically surrounds the central region. A diopter of the annular region is different from a diopter of the central region. The multifocal contact lens is immersed in the buffer solution, and the buffer solution includes a cycloplegic agent.

Claims (29)

1 . A contact lens product, comprising:

a multifocal contact lens made of a silicone hydrogel, comprising:

a central region; and

at least one annular region concentrically surrounding the central region, wherein a diopter of the annular region is different from a diopter of the central region, and the annular region closest to a periphery of the multifocal contact lens is a first annular region; and

a buffer solution, wherein the multifocal contact lens is immersed in the buffer solution, and the buffer solution comprises a cycloplegic agent;

wherein a composition for manufacturing the silicone hydrogel comprises 2-hydroxyethyl methacrylate and 3-methacryloyloxypropyltris(trimethylsilyloxy)silane;

wherein a weight percentage concentration of the 2-hydroxyethyl methacrylate in the composition for manufacturing the silicone hydrogel is 0.05% to 25%, and a weight percentage concentration of the 3-methacryloyloxypropyltris(trimethylsilyloxy)silane in the composition for manufacturing the silicone hydrogel is 0.1% to 40%;

wherein a weight percentage concentration of the cycloplegic agent in the buffer solution is ConA, the diopter of the central region of the multifocal contact lens is PowC, a maximum diopter of the first annular region of the multifocal contact lens is PowP1, a diameter of the central region of the multifocal contact lens is DiC, an outer diameter of the first annular region of the multifocal contact lens is DiP1, and the following conditions are satisfied:

ConA<0.5%;

2.25 D≤|PowC−PowP1|;

−5.50 D≤PowP1≤−0.50 D;

2 mm<DiC; and

0.15≤DiC/DiP1≤0.64.

2 . The contact lens product of claim 1 , wherein the weight percentage concentration of the cycloplegic agent in the buffer solution is ConA, and the following condition is satisfied:

0.01%<ConA<0.5%.

3 . The contact lens product of claim 2 , wherein the diopter of the central region of the multifocal contact lens is PowC, the maximum diopter of the first annular region of the multifocal contact lens is PowP1, and the following condition is satisfied:

2.50 D≤|PowC−PowP1|.

4 . The contact lens product of claim 1 , wherein the diameter of the central region of the multifocal contact lens is DiC, and the following condition is satisfied:

2 mm<DiC≤6 mm.

5 . The contact lens product of claim 4 , wherein the diameter of the central region of the multifocal contact lens is DiC, the outer diameter of the first annular region of the multifocal contact lens is DiP1, and the following condition is satisfied:

0.25≤DiC/DiP1≤0.53.

6 . The contact lens product of claim 1 , wherein the diopter of the central region of the multifocal contact lens is PowC, and the following condition is satisfied:

−5.00 D≤PowC≤−0.25 D.

7 . The contact lens product of claim 6 , wherein the diopter of the central region of the multifocal contact lens is PowC, and the following condition is satisfied:

−3.00 D≤PowC≤−1.00 D.

8 . The contact lens product of claim 1 , wherein a composition for manufacturing the multifocal contact lens comprises a blue-light blocking agent.

9 . The contact lens product of claim 1 , wherein a composition for manufacturing the multifocal contact lens comprises a UV (Ultraviolet) blocking agent.

10 . The contact lens product of claim 1 , wherein the weight percentage concentration of the 2-hydroxyethyl methacrylate in the composition for manufacturing the silicone hydrogel is 0.1% to 10%.

11 . The contact lens product of claim 1 , wherein the weight percentage concentration of the 3-methacryloyloxypropyltris(trimethylsilyloxy)silane in the composition for manufacturing the silicone hydrogel is 1% to 40%.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2022
From: LIN, EN-PING; CHEN, WEI-YUAN; TENG, CHUN-HUNG
To: LARGAN MEDICAL CO., LTD.
Reel/Frame 060921/0963 →
Priority Claims (2)
TW 104130460 · Sep 15, 2015 · national
TW 104135628 · Oct 29, 2015 · national
Continuity (4)
Continuation 16984301 · Aug 4, 2020
Continuation 16528775 · Aug 1, 2019
Continuation 15251007 · Aug 30, 2016
Related Publication 20230004022A1 · Jan 5, 2023
References Cited (91)
US 6045578A · Collins et al. · 2000 [cited by applicant]
US 6210005B1 · Portney · 2001 [cited by applicant]
US 7165840B2 · Yokoyama et al. · 2007 [cited by applicant]
US 8360576B2 · Pearson et al. · 2013 [cited by applicant]
US 8672474B2 · Lindacher et al. · 2014 [cited by applicant]
US 8783863B2 · Wang · 2014 [cited by applicant]
US 8998408B2 · Wei et al. · 2015 [cited by applicant]
US 9477097B2 · Holden et al. · 2016 [cited by applicant]
US 9827250B2 · Chehab et al. · 2017 [cited by applicant]
US 9987808B2 · Archer et al. · 2018 [cited by applicant]
US 10371965B2 · Lee et al. · 2019 [cited by applicant]
US 10416476B2 · Lin et al. · 2019 [cited by applicant]
US 20050074497A1 · Schultz · 2005 [cited by applicant]
US 20050105047A1 · Smith et al. · 2005 [cited by applicant]
US 20050254003A1 · Jani et al. · 2005 [cited by applicant]
US 20070115431A1 · Smith et al. · 2007 [cited by applicant]
US 20070126982A1 · Myung et al. · 2007 [cited by applicant]
US 20070159594A9 · Jani et al. · 2007 [cited by applicant]
US 20070222942A1 · Wooley et al. · 2007 [cited by applicant]
US 20070296916A1 · Holden et al. · 2007 [cited by applicant]
US 20080062380A1 · Phillips · 2008 [cited by applicant]
US 20080218687A1 · Phillips · 2008 [cited by applicant]
US 20080291393A1 · Menezes · 2008 [cited by applicant]
US 20090141235A1 · Collins et al. · 2009 [cited by applicant]
US 20090161065A1 · Leo et al. · 2009 [cited by applicant]
US 20090303434A1 · Tung · 2009 [cited by applicant]
US 20090303442A1 · Choo et al. · 2009 [cited by applicant]
US 20100036489A1 · Lindacher et al. · 2010 [cited by applicant]
US 20100073629A1 · Menezes · 2010 [cited by applicant]
US 20100195044A1 · Collins et al. · 2010 [cited by applicant]
US 20100296058A1 · Ho et al. · 2010 [cited by applicant]
US 20100328604A1 · Collins et al. · 2010 [cited by applicant]
US 20110001923A1 · Phillips · 2011 [cited by applicant]
US 20110051079A1 · Martinez et al. · 2011 [cited by applicant]
US 20110063567A1 · Domschke et al. · 2011 [cited by applicant]
US 20110153012A1 · Legerton et al. · 2011 [cited by applicant]
US 20120008217A1 · Ishak · 2012 [cited by examiner]
US 20120113386A1 · Back · 2012 [cited by applicant]
US 20120176582A1 · Back et al. · 2012 [cited by applicant]
US 20120194780A1 · Back · 2012 [cited by applicant]
US 20120320333A1 · Holden et al. · 2012 [cited by applicant]
US 20130010255A1 · Holden et al. · 2013 [cited by applicant]
US 20130109779A1 · Argal et al. · 2013 [cited by applicant]
US 20130182215A1 · Tung · 2013 [cited by applicant]
US 20130182216A1 · Ho et al. · 2013 [cited by applicant]
US 20130293834A1 · Wang · 2013 [cited by applicant]
US 20130314665A1 · Tung · 2013 [cited by applicant]
US 20140036225A1 · Chehab et al. · 2014 [cited by applicant]
US 20140132914A1 · Holden et al. · 2014 [cited by applicant]
US 20140132933A1 · Martinez et al. · 2014 [cited by applicant]
US 20140211147A1 · Wei · 2014 [cited by examiner]
US 20140320800A1 · Collins et al. · 2014 [cited by applicant]
US 20140347622A1 · Wu · 2014 [cited by applicant]
US 20150085247A1 · Holden et al. · 2015 [cited by applicant]
US 20150124212A1 · Loertscher et al. · 2015 [cited by applicant]
US 20150124213A1 · Collins et al. · 2015 [cited by applicant]
US 20160000314A1 · Drobe · 2016 [cited by applicant]
US 20160054588A1 · Brennan et al. · 2016 [cited by applicant]
US 20160062144A1 · Brennan et al. · 2016 [cited by applicant]
US 20160320634A1 · Ho et al. · 2016 [cited by applicant]
US 20170010478A1 · Holden et al. · 2017 [cited by applicant]
US 20170038603A1 · Holden et al. · 2017 [cited by applicant]
US 20170052390A1 · Tung · 2017 [cited by applicant]
US 20170146821A9 · Collins et al. · 2017 [cited by applicant]
US 20170146824A1 · Martinez et al. · 2017 [cited by applicant]
US 20170168320A1 · Tsubota et al. · 2017 [cited by applicant]
US 20170184875A1 · Newman · 2017 [cited by applicant]
US 20170192252A1 · Brennan et al. · 2017 [cited by applicant]
CN 102382237A · 2012 [cited by applicant]
CN 103389586A · 2013 [cited by applicant]
CN 103576337A · 2014 [cited by applicant]
EP 0742464A2 · 1996 [cited by applicant]
EP 2693259A1 · 2014 [cited by examiner]
EP 3144720A2 · 2017 [cited by applicant]
JP H06206820A · 1994 [cited by applicant]
JP H0926559A · 1997 [cited by applicant]
JP 2009540373A · 2009 [cited by applicant]
JP 2012526302A · 2012 [cited by applicant]
JP 2014032404A · 2014 [cited by applicant]
JP 2015102870A · 2015 [cited by applicant]
JP 2017058668A · 2017 [cited by applicant]
TW 201237502 · 2012 [cited by applicant]
TW 201237502A · 2012 [cited by applicant]
TW 201242942A · 2012 [cited by applicant]
TW 201243427A · 2012 [cited by applicant]
TW 201410265A · 2014 [cited by applicant]
TW 201447419A · 2014 [cited by applicant]
WO 2005016617A1 · 2005 [cited by applicant]
WO 2007146673A2 · 2007 [cited by applicant]
WO 2011045376A1 · 2011 [cited by applicant]
WO 2014177871A1 · 2014 [cited by applicant]